Similar Search Results

Distribution of health-related social surplus in pharmaceuticals : an estimation of consumer and producer surplus in the management of high blood lipids and COPD

Camejo, Rodrigo Refoios; McGrath, Clare; Miraldo, Marisa; … - In: The European journal of health economics : HEPAC ; … 15 (2014) 4, pp. 439-445

Persistent link: https://www.econbiz.de/10010383383

An empirical model of drug pricing and competition : a dynamic perspective

Camejo, Rodrigo Refoios; McGrath, Clare; Rutten, F. F. H. - In: International journal of economics and business research 6 (2013) 2, pp. 173-193

Persistent link: https://www.econbiz.de/10010351165

Reimbursement of pharmaceuticals : reference pricing versus health technology assessment

Drummond, Michael F.; Jönsson, Bengt; Rutten, F. F. H.; … - In: The European journal of health economics : HEPAC ; … 12 (2011) 3, pp. 263-271

Persistent link: https://www.econbiz.de/10009124305

R&D success in pharmaceutical markets : a duration model approach

Barrenho, Eliana; Miraldo, Marisa - In: Health econometrics, (pp. 201-233). 2018

Persistent link: https://www.econbiz.de/10011898934

CHAPTER 9 R&D Success in Pharmaceutical Markets: A Duration Model Approach

Barrenho, Eliana; Miraldo, Marisa - In: Health econometrics, (pp. 201-233). 2018

This chapter aims at providing an understanding of the research and devlopment (R&D) process in the pharmaceutical industry, by exploring the methodological challenges and approaches in the assessment of the determinants of innovation in the pharmaceutical industry. It (i) discusses possible...

Persistent link: https://www.econbiz.de/10015093853